“Chemotherapy-related agranulocytosis as a predictive factor for germline BRCA1 pathogenic variants in breast cancer patients: a retrospective cohort study” (2023) Swiss Medical Weekly, 153(3), p. 40055. doi:10.57187/smw.2023.40055.